A Study to Evaluate Pharmacokinetics, Safety and Tolerability of MEDI0382 in Renal Impairment Subjects
Clinical trial NCT03235375 · COMPLETED
Trial details
- NCT number
- NCT03235375
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-27
- Primary completion
- 2018-04-24
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.